Report Detail

Chemical & Material Global Medical Grade Polycaprolactone (PCL) Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4627257
  • |
  • 26 September, 2025
  • |
  • Global
  • |
  • 92 Pages
  • |
  • GIR
  • |
  • Chemical & Material

According to our (Global Info Research) latest study, the global Medical Grade Polycaprolactone (PCL) market size was valued at US$ 43.6 million in 2024 and is forecast to a readjusted size of USD 77.6 million by 2031 with a CAGR of 8.2% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Polycaprolactone (PCL) is a long-term biodegradable polyester with a low melting point of around 60°C and a glass transition temperature of about −60°C. PCL is prepared by ring-opening polymerization of ε-caprolactone and is FDA approved for drug delivery devices and as adhesion barriers. PCL is highly soluble in chlorinated hydrocarbons and can be used for thermal processing like extrusion, fiber spinning, injection molding and 3D-printing.
As a biodegradable polyester material, medical-grade polycaprolactone (PCL) has shown broad application prospects in the medical field due to its excellent biocompatibility, controllable degradability and mechanical properties.
In the global medical-grade PCL market, Ingevity, Daicel and Hunan Juren occupy the main market share. The core applications of medical-grade PCL include drug sustained-release systems, tissue engineering scaffolds, medical beauty regeneration materials and medical consumables (radiotherapy positioning mask), etc. The technical development direction focuses on personalized medicine and 3D printing (such as implantable PCL microspheres), composite biomaterials (such as PCL and hydroxyapatite composite scaffolds to shorten bone repair time by 30%), intelligence (pH-sensitive PCL to achieve precise drug release) and green manufacturing.
This report is a detailed and comprehensive analysis for global Medical Grade Polycaprolactone (PCL) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Medical Grade Polycaprolactone (PCL) market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2020-2031
Global Medical Grade Polycaprolactone (PCL) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2020-2031
Global Medical Grade Polycaprolactone (PCL) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2020-2031
Global Medical Grade Polycaprolactone (PCL) market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Kg), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Medical Grade Polycaprolactone (PCL)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Medical Grade Polycaprolactone (PCL) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ingevity, Daicel, Evonik, Corbion, Hunan Juren Chemical Hitechnology, eSUNMED, Shenzhen Polymtek Biomaterial, Sinopec Hunan Petrochemical, Weibo (Shenzhen), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Medical Grade Polycaprolactone (PCL) market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Ordinary Polycaprolactone
Polycaprolactone Microspheres
Market segment by Application
Medical Device
Medical Beauty
Drug Sustained Release
Others
Major players covered
Ingevity
Daicel
Evonik
Corbion
Hunan Juren Chemical Hitechnology
eSUNMED
Shenzhen Polymtek Biomaterial
Sinopec Hunan Petrochemical
Weibo (Shenzhen)
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Medical Grade Polycaprolactone (PCL) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Medical Grade Polycaprolactone (PCL), with price, sales quantity, revenue, and global market share of Medical Grade Polycaprolactone (PCL) from 2020 to 2025.
Chapter 3, the Medical Grade Polycaprolactone (PCL) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Medical Grade Polycaprolactone (PCL) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Medical Grade Polycaprolactone (PCL) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Medical Grade Polycaprolactone (PCL).
Chapter 14 and 15, to describe Medical Grade Polycaprolactone (PCL) sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Medical Grade Polycaprolactone (PCL) Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Ordinary Polycaprolactone
    • 1.3.3 Polycaprolactone Microspheres
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Medical Grade Polycaprolactone (PCL) Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Medical Device
    • 1.4.3 Medical Beauty
    • 1.4.4 Drug Sustained Release
    • 1.4.5 Others
  • 1.5 Global Medical Grade Polycaprolactone (PCL) Market Size & Forecast
    • 1.5.1 Global Medical Grade Polycaprolactone (PCL) Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Medical Grade Polycaprolactone (PCL) Sales Quantity (2020-2031)
    • 1.5.3 Global Medical Grade Polycaprolactone (PCL) Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Ingevity
    • 2.1.1 Ingevity Details
    • 2.1.2 Ingevity Major Business
    • 2.1.3 Ingevity Medical Grade Polycaprolactone (PCL) Product and Services
    • 2.1.4 Ingevity Medical Grade Polycaprolactone (PCL) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Ingevity Recent Developments/Updates
  • 2.2 Daicel
    • 2.2.1 Daicel Details
    • 2.2.2 Daicel Major Business
    • 2.2.3 Daicel Medical Grade Polycaprolactone (PCL) Product and Services
    • 2.2.4 Daicel Medical Grade Polycaprolactone (PCL) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Daicel Recent Developments/Updates
  • 2.3 Evonik
    • 2.3.1 Evonik Details
    • 2.3.2 Evonik Major Business
    • 2.3.3 Evonik Medical Grade Polycaprolactone (PCL) Product and Services
    • 2.3.4 Evonik Medical Grade Polycaprolactone (PCL) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Evonik Recent Developments/Updates
  • 2.4 Corbion
    • 2.4.1 Corbion Details
    • 2.4.2 Corbion Major Business
    • 2.4.3 Corbion Medical Grade Polycaprolactone (PCL) Product and Services
    • 2.4.4 Corbion Medical Grade Polycaprolactone (PCL) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Corbion Recent Developments/Updates
  • 2.5 Hunan Juren Chemical Hitechnology
    • 2.5.1 Hunan Juren Chemical Hitechnology Details
    • 2.5.2 Hunan Juren Chemical Hitechnology Major Business
    • 2.5.3 Hunan Juren Chemical Hitechnology Medical Grade Polycaprolactone (PCL) Product and Services
    • 2.5.4 Hunan Juren Chemical Hitechnology Medical Grade Polycaprolactone (PCL) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Hunan Juren Chemical Hitechnology Recent Developments/Updates
  • 2.6 eSUNMED
    • 2.6.1 eSUNMED Details
    • 2.6.2 eSUNMED Major Business
    • 2.6.3 eSUNMED Medical Grade Polycaprolactone (PCL) Product and Services
    • 2.6.4 eSUNMED Medical Grade Polycaprolactone (PCL) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 eSUNMED Recent Developments/Updates
  • 2.7 Shenzhen Polymtek Biomaterial
    • 2.7.1 Shenzhen Polymtek Biomaterial Details
    • 2.7.2 Shenzhen Polymtek Biomaterial Major Business
    • 2.7.3 Shenzhen Polymtek Biomaterial Medical Grade Polycaprolactone (PCL) Product and Services
    • 2.7.4 Shenzhen Polymtek Biomaterial Medical Grade Polycaprolactone (PCL) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Shenzhen Polymtek Biomaterial Recent Developments/Updates
  • 2.8 Sinopec Hunan Petrochemical
    • 2.8.1 Sinopec Hunan Petrochemical Details
    • 2.8.2 Sinopec Hunan Petrochemical Major Business
    • 2.8.3 Sinopec Hunan Petrochemical Medical Grade Polycaprolactone (PCL) Product and Services
    • 2.8.4 Sinopec Hunan Petrochemical Medical Grade Polycaprolactone (PCL) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Sinopec Hunan Petrochemical Recent Developments/Updates
  • 2.9 Weibo (Shenzhen)
    • 2.9.1 Weibo (Shenzhen) Details
    • 2.9.2 Weibo (Shenzhen) Major Business
    • 2.9.3 Weibo (Shenzhen) Medical Grade Polycaprolactone (PCL) Product and Services
    • 2.9.4 Weibo (Shenzhen) Medical Grade Polycaprolactone (PCL) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Weibo (Shenzhen) Recent Developments/Updates

3 Competitive Environment: Medical Grade Polycaprolactone (PCL) by Manufacturer

  • 3.1 Global Medical Grade Polycaprolactone (PCL) Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Medical Grade Polycaprolactone (PCL) Revenue by Manufacturer (2020-2025)
  • 3.3 Global Medical Grade Polycaprolactone (PCL) Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Medical Grade Polycaprolactone (PCL) by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Medical Grade Polycaprolactone (PCL) Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Medical Grade Polycaprolactone (PCL) Manufacturer Market Share in 2024
  • 3.5 Medical Grade Polycaprolactone (PCL) Market: Overall Company Footprint Analysis
    • 3.5.1 Medical Grade Polycaprolactone (PCL) Market: Region Footprint
    • 3.5.2 Medical Grade Polycaprolactone (PCL) Market: Company Product Type Footprint
    • 3.5.3 Medical Grade Polycaprolactone (PCL) Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Medical Grade Polycaprolactone (PCL) Market Size by Region
    • 4.1.1 Global Medical Grade Polycaprolactone (PCL) Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Medical Grade Polycaprolactone (PCL) Consumption Value by Region (2020-2031)
    • 4.1.3 Global Medical Grade Polycaprolactone (PCL) Average Price by Region (2020-2031)
  • 4.2 North America Medical Grade Polycaprolactone (PCL) Consumption Value (2020-2031)
  • 4.3 Europe Medical Grade Polycaprolactone (PCL) Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Medical Grade Polycaprolactone (PCL) Consumption Value (2020-2031)
  • 4.5 South America Medical Grade Polycaprolactone (PCL) Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Medical Grade Polycaprolactone (PCL) Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Medical Grade Polycaprolactone (PCL) Sales Quantity by Type (2020-2031)
  • 5.2 Global Medical Grade Polycaprolactone (PCL) Consumption Value by Type (2020-2031)
  • 5.3 Global Medical Grade Polycaprolactone (PCL) Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Medical Grade Polycaprolactone (PCL) Sales Quantity by Application (2020-2031)
  • 6.2 Global Medical Grade Polycaprolactone (PCL) Consumption Value by Application (2020-2031)
  • 6.3 Global Medical Grade Polycaprolactone (PCL) Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Medical Grade Polycaprolactone (PCL) Sales Quantity by Type (2020-2031)
  • 7.2 North America Medical Grade Polycaprolactone (PCL) Sales Quantity by Application (2020-2031)
  • 7.3 North America Medical Grade Polycaprolactone (PCL) Market Size by Country
    • 7.3.1 North America Medical Grade Polycaprolactone (PCL) Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Medical Grade Polycaprolactone (PCL) Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Medical Grade Polycaprolactone (PCL) Sales Quantity by Type (2020-2031)
  • 8.2 Europe Medical Grade Polycaprolactone (PCL) Sales Quantity by Application (2020-2031)
  • 8.3 Europe Medical Grade Polycaprolactone (PCL) Market Size by Country
    • 8.3.1 Europe Medical Grade Polycaprolactone (PCL) Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Medical Grade Polycaprolactone (PCL) Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Medical Grade Polycaprolactone (PCL) Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Medical Grade Polycaprolactone (PCL) Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Medical Grade Polycaprolactone (PCL) Market Size by Region
    • 9.3.1 Asia-Pacific Medical Grade Polycaprolactone (PCL) Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Medical Grade Polycaprolactone (PCL) Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Medical Grade Polycaprolactone (PCL) Sales Quantity by Type (2020-2031)
  • 10.2 South America Medical Grade Polycaprolactone (PCL) Sales Quantity by Application (2020-2031)
  • 10.3 South America Medical Grade Polycaprolactone (PCL) Market Size by Country
    • 10.3.1 South America Medical Grade Polycaprolactone (PCL) Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Medical Grade Polycaprolactone (PCL) Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Medical Grade Polycaprolactone (PCL) Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Medical Grade Polycaprolactone (PCL) Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Medical Grade Polycaprolactone (PCL) Market Size by Country
    • 11.3.1 Middle East & Africa Medical Grade Polycaprolactone (PCL) Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Medical Grade Polycaprolactone (PCL) Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Medical Grade Polycaprolactone (PCL) Market Drivers
  • 12.2 Medical Grade Polycaprolactone (PCL) Market Restraints
  • 12.3 Medical Grade Polycaprolactone (PCL) Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Medical Grade Polycaprolactone (PCL) and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Medical Grade Polycaprolactone (PCL)
  • 13.3 Medical Grade Polycaprolactone (PCL) Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Medical Grade Polycaprolactone (PCL) Typical Distributors
  • 14.3 Medical Grade Polycaprolactone (PCL) Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Medical Grade Polycaprolactone (PCL). Industry analysis & Market Report on Medical Grade Polycaprolactone (PCL) is a syndicated market report, published as Global Medical Grade Polycaprolactone (PCL) Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Medical Grade Polycaprolactone (PCL) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report